Patent details

EP3528786 Title: LIQUID FORMULATIONS OF DAPTOMYCIN

Basic Information

Publication number:
EP3528786
PCT Application Number:
EP2017076519
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177946779
PCT Publication Number:
WO2018073269
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LIQUID FORMULATIONS OF DAPTOMYCIN
French Title of Invention:
FORMULATIONS LIQUIDES DE DAPTOMYCINE
German Title of Invention:
FLÜSSIGE FORMULIERUNG VON DAPTOMYCIN
SPC Number:

Dates

Filing date:
17/10/2017
Grant date:
05/04/2023
EP Publication Date:
28/08/2019
PCT Publication Date:
26/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/04/2023
EP B1 Publication Date:
05/04/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/10/2023
Expiration date:
17/10/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/03/2023
 
 

Name:
Xellia Pharmaceuticals ApS
Address:
Dalslandsgade 11, 2300 Copenhagen S, Denmark (DK)

Inventor

1

Name:
STRAZIC, Dubravka
Address:
Croatia (HR)

2

Name:
GJONI, Tina
Address:
Croatia (HR)

Priority

Priority Number:
201662411024 P
Priority Date:
21/10/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/08; A61K 38/12;

Publication

European Patent Bulletin

Issue number:
202314
Publication date:
05/04/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages